Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.

BACKGROUND A subset of patients with hereditary hemorrhagic telangiectasia (HHT) develops pulmonary hypertension (PH) by mechanisms including pulmonary arterial hypertension, high flow, and elevated pulmonary arterial wedge pressure (PAWP). We aimed to describe echocardiographic and hemodynamic characteristics of patients with coexisting HHT and PH. METHODS We conducted a single-center cohort study of patients with confirmed HHT who underwent right-sided heart catheterization (RHC) and transthoracic two-dimensional echocardiography for suspected PH between June 1, 2003 and September 1, 2013 at Mayo Clinic Rochester, Minnesota. RESULTS Of 38 patients with confirmed HHT who underwent RHC and echocardiography, 28 (74%) had a mean pulmonary artery pressure (MPAP) ≥ 25 mm Hg. Of those 28, 12 (43%) had pulmonary arterial hypertension. Two patients had normal PAWP and pulmonary vascular resistance (PVR), with PH secondary to either an atrial septal defect or high cardiac flow. Fourteen patients (50%) had elevated PAWP (≥ 15 mm Hg), nine with evidence of high flow. RHC in all 28 patients demonstrated a MPAP of 41 ± 11 mm Hg, PAWP of 17 ± 10 mm Hg, and PVR of 4.5 ± 4.2 Wood units. Echocardiography demonstrated moderate/severe right ventricular dysfunction in nine patients (32%). The presence of PH trended toward worse survival (P = .06). CONCLUSIONS PH in patients with HHT occurs by different mechanisms, and there is a trend toward worse survival in patients who develop PH despite the mechanism. The equal predilection toward all subtypes of PH illustrates the necessity of RHC to clarify the hemodynamics.

[1]  O. Corcos,et al.  Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. , 2013, Journal of clinical gastroenterology.

[2]  M. Humbert,et al.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[3]  A. Guttmacher,et al.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.

[4]  M. Gatzoulis,et al.  [Updated clinical classification of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[5]  L. Sinak,et al.  Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. , 2013, Chest.

[6]  M. Freire,et al.  High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2013, European journal of internal medicine.

[7]  R. Trembath,et al.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia , 2003, Journal of medical genetics.

[8]  F. D'Ovidio,et al.  Life expectancy in patients with hereditary haemorrhagic telangiectasia. , 2006, QJM : monthly journal of the Association of Physicians.

[9]  V. Cottin,et al.  Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler Disease) , 2007, Respiration.

[10]  A. Stanson,et al.  Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. , 1999, Mayo Clinic proceedings.

[11]  A. Rotondo,et al.  Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. , 2004, Radiology.

[12]  J. Viale,et al.  Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. , 1999, Gastroenterology.

[13]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[14]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[15]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[16]  A. Arroliga,et al.  Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. , 2007, Chest.

[17]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  E. Buscarini,et al.  Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia , 2006, Genetics in Medicine.

[19]  J. Stockman Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output , 2013 .

[20]  J. Belghiti,et al.  Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.

[21]  A. Alexopoulou,et al.  Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia , 2013, Expert opinion on biological therapy.

[22]  H. Plauchu,et al.  Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. , 1993, Gastroenterology.

[23]  D. Badesch,et al.  [Definitions and diagnosis of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[24]  E. Buscarini,et al.  Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. , 2013, Chest.

[25]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[26]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[27]  J. Simon R. Gibbs,et al.  [Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2010, Revue des maladies respiratoires.